
The panelist discusses how understanding the diverse manifestations of atopic dermatitis enables health care providers to develop personalized treatment approaches for optimal patient outcomes.

The panelist discusses how understanding the diverse manifestations of atopic dermatitis enables health care providers to develop personalized treatment approaches for optimal patient outcomes.

The panelist discusses how to evaluate and select appropriate therapeutic options for a 10-year-old girl while considering factors such as safety, efficacy, and treatment adherence.

The panelist discusses how to effectively communicate the benefits and potential adverse effects of dupilumab treatment to patients and their families to support informed decision-making.

The panelist discusses how to optimize topical therapy selection and application strategies for a young man with mild atopic dermatitis to achieve symptom control and maintain skin barrier function.

The panelist discusses how to evaluate the need for and manage the transition between biologic therapies in a 32-year-old woman with severe atopic dermatitis who has had an inadequate response to initial treatment.

The panelist discusses how to safely transition a 36-year-old man with a history of systemic corticosteroid use to appropriate oral treatment options while monitoring for potential complications.

The panelist discusses how the therapeutic options for atopic dermatitis have expanded significantly with the emergence of targeted biologics, oral agents, and refined topical treatments, transforming the management approach for patients across the disease spectrum.

In a recent Dermatology Times Case-Based Peer Perspectives custom video series, Naiem Issa, MD, PhD, reviewed 3 complex patient cases of atopic dermatitis.